Mutations in BRCA genes are linked to the early onset of breast and ovarian cancers. But the effect of most mutations is unclear. Now new research can distinguish harmless from dangerous mutations.
New tool helps find genetic culprits in cancer's spread
John Martin on LinkedIn: CRISPR 'barcodes' map mammalian development in exquisite detail
Ovarian cancer – News, Research and Analysis – The Conversation – page 1
Gene-editing technique CRISPR identifies dangerous breast cancer mutations
CRISPR/Cas genome editing tool in the age of cancer treatment.
Early-onset cancer – News, Research and Analysis – The Conversation – page 1
COVID-19 variants – News, Research and Analysis – The Conversation – page 7
Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy, Molecular Cancer
BRCA2 – News, Research and Analysis – The Conversation – page 1